Indivior Pharmaceuticals (INDV) Debt Ratio (2023 - 2026)

Indivior Pharmaceuticals' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.41 for Q1 2026.

• On a quarterly basis, Debt Ratio rose 69.69% year-over-year to 0.41 in Q1 2026; TTM through Mar 2026 was 0.41, a 69.69% increase from a year earlier, with the FY2025 full-year figure at 0.27, up 4.97% from the prior year.
• Debt Ratio climbed to 0.41 in Q1 2026 per INDV's latest filing, from 0.27 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.41 in Q1 2026 and bottomed at 0.14 in Q4 2023.
• The 4-year median for Debt Ratio is 0.24 (2025), against an average of 0.25.
• Across the five-year window, Debt Ratio surged 85.35% in 2024 and climbed 4.97% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.14 in 2023, then surged by 85.35% to 0.25 in 2024, then grew by 4.97% to 0.27 in 2025, then surged by 52.86% to 0.41 in 2026.
• Per Business Quant, the three latest INDV Debt Ratio figures stand at 0.41 (Q1 2026), 0.27 (Q4 2025), and 0.23 (Q3 2025).